SGMO - Sangamo shares fall after hours as Q1 net loss widens misses on EPS

Sangamo Therapeutics (SGMO) is down 2.3% after-hours after its Q1 net loss widened year-over-year and it missed on EPS.Q1 net loss was $45.9M ($0.32 per share), compared to a net loss of $42.9M ($0.37 per share) in the prior-year period.Revenues doubled in the quarter to $26.3M from $13.1M.For the year, Sangamo expects total operating expenses of between $255M and $275M.The genomics medicine company ended the quarter with $629.5 million in cash.Sangamo shares are down 2.3% to $11.10 in after-hours trading.

For further details see:

Sangamo shares fall after hours as Q1 net loss widens, misses on EPS